nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—Gadobenate Dimeglumine—ALB—atherosclerosis	0.0139	1	CrCbGaD
Gadopentetate dimeglumine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00569	0.00577	CcSEcCtD
Gadopentetate dimeglumine—Diplopia—Pravastatin—atherosclerosis	0.00559	0.00567	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Niacin—atherosclerosis	0.00559	0.00567	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00557	0.00565	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Niacin—atherosclerosis	0.00548	0.00556	CcSEcCtD
Gadopentetate dimeglumine—Abdominal discomfort—Lovastatin—atherosclerosis	0.00548	0.00556	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Rosuvastatin—atherosclerosis	0.00541	0.00549	CcSEcCtD
Gadopentetate dimeglumine—Abdominal discomfort—Simvastatin—atherosclerosis	0.00512	0.0052	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00504	0.00511	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Pravastatin—atherosclerosis	0.005	0.00507	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00482	0.00489	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Niacin—atherosclerosis	0.00478	0.00485	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Rosuvastatin—atherosclerosis	0.00473	0.0048	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00473	0.00479	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Pravastatin—atherosclerosis	0.00471	0.00477	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Ezetimibe—atherosclerosis	0.00442	0.00448	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00441	0.00447	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Lovastatin—atherosclerosis	0.00433	0.00439	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Rosuvastatin—atherosclerosis	0.00429	0.00435	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00425	0.00431	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Lovastatin—atherosclerosis	0.00425	0.00431	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00424	0.0043	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Pravastatin—atherosclerosis	0.00422	0.00428	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Niacin—atherosclerosis	0.0042	0.00425	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Ezetimibe—atherosclerosis	0.00416	0.00422	CcSEcCtD
Gadopentetate dimeglumine—Chills—Lovastatin—atherosclerosis	0.0041	0.00416	CcSEcCtD
Gadopentetate dimeglumine—Cough—Rosuvastatin—atherosclerosis	0.0041	0.00416	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Ezetimibe—atherosclerosis	0.00407	0.00413	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Ezetimibe—atherosclerosis	0.00405	0.00411	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Simvastatin—atherosclerosis	0.00405	0.0041	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00404	0.0041	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Rosuvastatin—atherosclerosis	0.004	0.00406	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Simvastatin—atherosclerosis	0.00397	0.00403	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Niacin—atherosclerosis	0.00394	0.00399	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Ezetimibe—atherosclerosis	0.00393	0.00399	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Ezetimibe—atherosclerosis	0.00391	0.00396	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Lovastatin—atherosclerosis	0.0039	0.00395	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Pravastatin—atherosclerosis	0.00388	0.00393	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Niacin—atherosclerosis	0.00387	0.00392	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Rosuvastatin—atherosclerosis	0.00387	0.00392	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Lovastatin—atherosclerosis	0.00385	0.00391	CcSEcCtD
Gadopentetate dimeglumine—Chills—Simvastatin—atherosclerosis	0.00384	0.00389	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Niacin—atherosclerosis	0.00379	0.00384	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Ezetimibe—atherosclerosis	0.00378	0.00383	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00376	0.00381	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Simvastatin—atherosclerosis	0.00375	0.0038	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Lovastatin—atherosclerosis	0.00373	0.00378	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Pravastatin—atherosclerosis	0.00373	0.00378	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Simvastatin—atherosclerosis	0.00372	0.00378	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Niacin—atherosclerosis	0.00367	0.00372	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Niacin—atherosclerosis	0.00366	0.00371	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Pravastatin—atherosclerosis	0.00366	0.00371	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Simvastatin—atherosclerosis	0.00365	0.0037	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Niacin—atherosclerosis	0.00365	0.0037	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Lovastatin—atherosclerosis	0.00364	0.00369	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Pravastatin—atherosclerosis	0.00361	0.00366	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Lovastatin—atherosclerosis	0.00359	0.00364	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Pravastatin—atherosclerosis	0.00359	0.00364	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Pravastatin—atherosclerosis	0.00359	0.00364	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Ezetimibe—atherosclerosis	0.00357	0.00362	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Niacin—atherosclerosis	0.00356	0.00361	CcSEcCtD
Gadopentetate dimeglumine—Chills—Niacin—atherosclerosis	0.00353	0.00357	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Ezetimibe—atherosclerosis	0.00352	0.00357	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Niacin—atherosclerosis	0.00351	0.00356	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00349	0.00354	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Simvastatin—atherosclerosis	0.00349	0.00354	CcSEcCtD
Gadopentetate dimeglumine—Chills—Pravastatin—atherosclerosis	0.00347	0.00352	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Pravastatin—atherosclerosis	0.00346	0.0035	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00344	0.00349	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Niacin—atherosclerosis	0.00342	0.00347	CcSEcCtD
Gadopentetate dimeglumine—Cough—Ezetimibe—atherosclerosis	0.00341	0.00346	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Simvastatin—atherosclerosis	0.0034	0.00345	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Lovastatin—atherosclerosis	0.00339	0.00344	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Lovastatin—atherosclerosis	0.00339	0.00344	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Lovastatin—atherosclerosis	0.00338	0.00343	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Ezetimibe—atherosclerosis	0.00337	0.00342	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Simvastatin—atherosclerosis	0.00336	0.00341	CcSEcCtD
Gadopentetate dimeglumine—Tension—Niacin—atherosclerosis	0.00336	0.0034	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Ezetimibe—atherosclerosis	0.00333	0.00337	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Ezetimibe—atherosclerosis	0.00333	0.00337	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Lovastatin—atherosclerosis	0.00332	0.00336	CcSEcCtD
Gadopentetate dimeglumine—Tension—Pravastatin—atherosclerosis	0.0033	0.00335	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.0033	0.00335	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Pravastatin—atherosclerosis	0.0033	0.00334	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Rosuvastatin—atherosclerosis	0.00328	0.00333	CcSEcCtD
Gadopentetate dimeglumine—Pain—Rosuvastatin—atherosclerosis	0.00328	0.00333	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Lovastatin—atherosclerosis	0.00328	0.00332	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Ezetimibe—atherosclerosis	0.00325	0.0033	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00325	0.0033	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Ezetimibe—atherosclerosis	0.00321	0.00326	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00319	0.00323	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Simvastatin—atherosclerosis	0.00317	0.00322	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Simvastatin—atherosclerosis	0.00317	0.00322	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00316	0.0032	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Simvastatin—atherosclerosis	0.00316	0.0032	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Pravastatin—atherosclerosis	0.00315	0.0032	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00314	0.00318	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00313	0.00317	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Niacin—atherosclerosis	0.00313	0.00317	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Lovastatin—atherosclerosis	0.0031	0.00314	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Ezetimibe—atherosclerosis	0.0031	0.00314	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Pravastatin—atherosclerosis	0.00308	0.00312	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Niacin—atherosclerosis	0.00307	0.00311	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Simvastatin—atherosclerosis	0.00307	0.00311	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Rosuvastatin—atherosclerosis	0.00305	0.00309	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00304	0.00308	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Pravastatin—atherosclerosis	0.00304	0.00308	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00303	0.00307	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Niacin—atherosclerosis	0.00301	0.00305	CcSEcCtD
Gadopentetate dimeglumine—Cough—Niacin—atherosclerosis	0.00298	0.00303	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00296	0.003	CcSEcCtD
Gadopentetate dimeglumine—Cough—Pravastatin—atherosclerosis	0.00294	0.00298	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Lovastatin—atherosclerosis	0.00292	0.00296	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Niacin—atherosclerosis	0.00291	0.00295	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Pravastatin—atherosclerosis	0.00291	0.00295	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.0029	0.00295	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Simvastatin—atherosclerosis	0.0029	0.00294	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Lovastatin—atherosclerosis	0.0029	0.00294	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00289	0.00293	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Pravastatin—atherosclerosis	0.00287	0.00291	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Pravastatin—atherosclerosis	0.00287	0.00291	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Ezetimibe—atherosclerosis	0.00286	0.0029	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Pravastatin—atherosclerosis	0.00286	0.0029	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Niacin—atherosclerosis	0.00285	0.00289	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Ezetimibe—atherosclerosis	0.00284	0.00288	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00283	0.00287	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Lovastatin—atherosclerosis	0.00283	0.00286	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Lovastatin—atherosclerosis	0.0028	0.00284	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Niacin—atherosclerosis	0.00279	0.00283	CcSEcCtD
Gadopentetate dimeglumine—Pain—Lovastatin—atherosclerosis	0.00278	0.00282	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Lovastatin—atherosclerosis	0.00278	0.00282	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Pravastatin—atherosclerosis	0.00277	0.00281	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Ezetimibe—atherosclerosis	0.00277	0.00281	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00277	0.00281	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00275	0.00279	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Rosuvastatin—atherosclerosis	0.00275	0.00279	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00275	0.00279	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Ezetimibe—atherosclerosis	0.00275	0.00279	CcSEcCtD
Gadopentetate dimeglumine—Shock—Niacin—atherosclerosis	0.00275	0.00278	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Simvastatin—atherosclerosis	0.00273	0.00277	CcSEcCtD
Gadopentetate dimeglumine—Pain—Ezetimibe—atherosclerosis	0.00273	0.00276	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Ezetimibe—atherosclerosis	0.00273	0.00276	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Niacin—atherosclerosis	0.00272	0.00276	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Rosuvastatin—atherosclerosis	0.00271	0.00275	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Niacin—atherosclerosis	0.00271	0.00275	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Simvastatin—atherosclerosis	0.00271	0.00275	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Niacin—atherosclerosis	0.0027	0.00274	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Lovastatin—atherosclerosis	0.00268	0.00272	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Niacin—atherosclerosis	0.00266	0.0027	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00266	0.00269	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00266	0.00269	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Simvastatin—atherosclerosis	0.00264	0.00268	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00263	0.00266	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00262	0.00266	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00262	0.00266	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Simvastatin—atherosclerosis	0.00262	0.00266	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Pravastatin—atherosclerosis	0.00262	0.00266	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Niacin—atherosclerosis	0.00261	0.00264	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00261	0.00264	CcSEcCtD
Gadopentetate dimeglumine—Pain—Simvastatin—atherosclerosis	0.0026	0.00264	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Simvastatin—atherosclerosis	0.0026	0.00264	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Lovastatin—atherosclerosis	0.00258	0.00262	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Lovastatin—atherosclerosis	0.00257	0.00261	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Lovastatin—atherosclerosis	0.00257	0.00261	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00254	0.00258	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Rosuvastatin—atherosclerosis	0.00254	0.00257	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Ezetimibe—atherosclerosis	0.00253	0.00257	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Ezetimibe—atherosclerosis	0.00252	0.00256	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Ezetimibe—atherosclerosis	0.00252	0.00256	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Niacin—atherosclerosis	0.00251	0.00254	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Simvastatin—atherosclerosis	0.00251	0.00254	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.0025	0.00254	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Niacin—atherosclerosis	0.00249	0.00252	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00249	0.00252	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Niacin—atherosclerosis	0.00248	0.00252	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Pravastatin—atherosclerosis	0.00247	0.0025	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Pravastatin—atherosclerosis	0.00245	0.00248	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Niacin—atherosclerosis	0.00243	0.00246	CcSEcCtD
Gadopentetate dimeglumine—Rash—Rosuvastatin—atherosclerosis	0.00242	0.00245	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Rosuvastatin—atherosclerosis	0.00242	0.00245	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Simvastatin—atherosclerosis	0.00241	0.00245	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00241	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Simvastatin—atherosclerosis	0.0024	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Simvastatin—atherosclerosis	0.0024	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Headache—Rosuvastatin—atherosclerosis	0.0024	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Lovastatin—atherosclerosis	0.00239	0.00243	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Pravastatin—atherosclerosis	0.00239	0.00242	CcSEcCtD
Gadopentetate dimeglumine—Pain—Niacin—atherosclerosis	0.00239	0.00242	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Pravastatin—atherosclerosis	0.00237	0.0024	CcSEcCtD
Gadopentetate dimeglumine—Pain—Pravastatin—atherosclerosis	0.00235	0.00238	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Pravastatin—atherosclerosis	0.00235	0.00238	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00235	0.00238	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Lovastatin—atherosclerosis	0.00233	0.00236	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Lovastatin—atherosclerosis	0.0023	0.00233	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Ezetimibe—atherosclerosis	0.00229	0.00232	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Niacin—atherosclerosis	0.00228	0.00231	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Rosuvastatin—atherosclerosis	0.00228	0.00231	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Pravastatin—atherosclerosis	0.00226	0.0023	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Ezetimibe—atherosclerosis	0.00226	0.00229	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00225	0.00228	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Simvastatin—atherosclerosis	0.00224	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Lovastatin—atherosclerosis	0.00222	0.00225	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Niacin—atherosclerosis	0.00222	0.00225	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Niacin—atherosclerosis	0.00221	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Niacin—atherosclerosis	0.00221	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Pravastatin—atherosclerosis	0.00218	0.00221	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Simvastatin—atherosclerosis	0.00218	0.00221	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Ezetimibe—atherosclerosis	0.00218	0.00221	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Pravastatin—atherosclerosis	0.00217	0.0022	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Pravastatin—atherosclerosis	0.00217	0.0022	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Simvastatin—atherosclerosis	0.00215	0.00218	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Lovastatin—atherosclerosis	0.00215	0.00218	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Ezetimibe—atherosclerosis	0.00211	0.00214	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Simvastatin—atherosclerosis	0.00208	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Lovastatin—atherosclerosis	0.00207	0.0021	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Niacin—atherosclerosis	0.00206	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Rash—Lovastatin—atherosclerosis	0.00205	0.00208	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Lovastatin—atherosclerosis	0.00205	0.00208	CcSEcCtD
Gadopentetate dimeglumine—Headache—Lovastatin—atherosclerosis	0.00204	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Ezetimibe—atherosclerosis	0.00203	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Pravastatin—atherosclerosis	0.00202	0.00205	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Simvastatin—atherosclerosis	0.00201	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Rash—Ezetimibe—atherosclerosis	0.00201	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Ezetimibe—atherosclerosis	0.00201	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Niacin—atherosclerosis	0.002	0.00203	CcSEcCtD
Gadopentetate dimeglumine—Headache—Ezetimibe—atherosclerosis	0.002	0.00203	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Niacin—atherosclerosis	0.00197	0.002	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Pravastatin—atherosclerosis	0.00197	0.002	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Pravastatin—atherosclerosis	0.00194	0.00197	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Simvastatin—atherosclerosis	0.00193	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Lovastatin—atherosclerosis	0.00193	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Rash—Simvastatin—atherosclerosis	0.00192	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Simvastatin—atherosclerosis	0.00191	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Niacin—atherosclerosis	0.00191	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Headache—Simvastatin—atherosclerosis	0.0019	0.00193	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Ezetimibe—atherosclerosis	0.00189	0.00192	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Pravastatin—atherosclerosis	0.00188	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Niacin—atherosclerosis	0.00185	0.00187	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Pravastatin—atherosclerosis	0.00182	0.00184	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Simvastatin—atherosclerosis	0.00181	0.00183	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Niacin—atherosclerosis	0.00177	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Rash—Niacin—atherosclerosis	0.00176	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Niacin—atherosclerosis	0.00176	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Headache—Niacin—atherosclerosis	0.00175	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Pravastatin—atherosclerosis	0.00175	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Rash—Pravastatin—atherosclerosis	0.00173	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Pravastatin—atherosclerosis	0.00173	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Headache—Pravastatin—atherosclerosis	0.00172	0.00175	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Niacin—atherosclerosis	0.00166	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Pravastatin—atherosclerosis	0.00163	0.00166	CcSEcCtD
